Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2024-04-29 00:00:00 ET · period of report 2024-04-26 · accession 0000950170-24-049854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-29 | 2024-04-26 | BEAM | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +12.5K | 82.6K | +18% | $0 |
| D | 2024-04-29 | 2024-04-26 | BEAM | Burrell Terry-Ann | CFO | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-26 | A | A | 12,500 | $0.00 | 82,637 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in three substantially equal annual installments on each of the first three anniversaries of September 30, 2023, subject to the Reporting Person's continued service with BEAM through each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-04-26 | A | A | 25,000 | $0.00 | 25,000 | D | $30.87 · — to 2034-04-26 | 25,000 Common Stock | (F2) This stock option vests in equal monthly installments each month following July 31, 2023 for the subsequent thirty-six months, subject to the Reporting Person's continued service with BEAM through each vesting date. |